ARCHIVES

Phase III Nexavar Trial Fails Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

Cancer Letter Office Moves To Capitol Hill; No Issues Published Next Two Weeks

September 1, 1989

Community Assn. Meeting Includes Provocative Workshops

January 31, 1975

Also in this 8-page issue: Amgen names PhRMA executive Rodger Currie vice president for government affairs.

April 30, 2004

NCAB Approves CCP, Agrees To Compromise On Including Control

May 21, 1982

NCI Moves To Suspend Researcher Amid Charges Contractor Made Mortgage And Other Payments

May 4, 1990

Funding Opportunities Listed.

January 21, 2005